Treating Cervical Cancer: What You Need to Know

There are a number of myths and misconceptions about treating cervical cancer. Understanding the facts is an important first step in making the best treatment choices.

7:00 AM

Author | Annette Schork, RN

Cervical cancer was once one of the most common cancers affecting U.S. women and now ranks 14th.

The rate has declined sharply with the introduction of the Pap test, a screening procedure that can find changes in the cervix before the cancer develops. The test can also help to find cervical cancer at an early stage.

LISTEN UP: Add the new Michigan Medicine News Break to your Alexa-enabled device, or subscribe to our daily audio updates on iTunes, Google Play and Stitcher.

Several risk factors increase a woman's chance of developing cervical cancer. The most important risk factor is infection caused by HPV, or human papillomavirus. Other risk factors include smoking, immunosuppression, chlamydia infection and being overweight.

SEE ALSO: Key Steps That Can Help Prevent Cervical Cancer

Treatment of cervical cancer depends on:

  • Stage of the cancer

  • Size and shape of the tumor

  • The woman's age and general health

  • Her desire to have children

There is a common myth among women that they must have a hysterectomy to treat cervical cancer. The truth is that while early cervical cancer is typically treated with a hysterectomy — surgery that removes the cervix and uterus — it's not the only option.

Avoiding a hysterectomy

Some women with early cervical cancer can avoid a hysterectomy with procedures such as a cone biopsy, which removes only the cancerous tissue and a small margin of surrounding healthy tissue, or a radical trachelectomy, which removes the cervix but not the uterus.

MORE FROM MICHIGAN: Sign up for our weekly newsletter

Radiation and chemotherapy are used to treat more advanced disease and may be options for women with early stage disease who cannot or do not want to have surgery.

SEE ALSO: Two Simple Steps to Prevent Cervical Cancer

Another misconception is that a woman loses the ability to bear children as a result of cervical cancer treatment. In cases of stage IA2 or stage IB cervical cancer, a radical trachelectomy may allow some women to be treated and still have children.

After trachelectomy, some women are able to carry a pregnancy to term and deliver a healthy baby by cesarean section. The risk of a cancer recurrence after this procedure is low.

Women should ask their doctors whether they are candidates for this procedure and consult with a gynecologic oncologist who is skilled in performing this procedure.

To reach an oncology nurse at the Cancer AnswerLine, call 800-865-1125.


More Articles About: Cancer Care Cervical Cancer Cancer AnswerLine Cancer: Cancer Types
Health Lab word mark overlaying blue cells
Health Lab

Explore a variety of health care news & stories by visiting the Health Lab home page for more articles.

Media Contact Public Relations

Department of Communication at Michigan Medicine

[email protected]

734-764-2220

Stay Informed

Want top health & research news weekly? Sign up for Health Lab’s newsletters today!

Subscribe
Featured News & Stories blue purple cell dots on white background all over in different patterns
Health Lab
Research finds possible therapies to target oncogenic transcription factors in multiple cancer types
A study from the University of Michigan Health Rogel Cancer Center furthers research that suggests the potential of developing new cancer treatments to target oncogenic transcription factors by indirectly affecting their ability to access enhancer DNA in chromatin.
colorful cells floating pink teal orange and green black vague background
Health Lab
Improving access to HPV testing
A new initiative is aiming to raise awareness and improve accessibility to HPV testing. Diane Harper, M.D., M.P.H. M.S., discusses it and the importance of screening for HPV.
cancer cell blue yellow
Health Lab
Accessibility issues in cancer care
Researchers at the University of Michigan are finding that many patients may be encountering significant barriers to cancer care, even from their first phone call to a clinic.
cancer cell blue yellow
Health Lab
Widening inequality seen where cancer clinical trials are available
The availability of clinical trials of new treatments for cancer varies greatly by geography, and a new study shows more socially vulnerable areas have far fewer.
Blue image of a microscopic helix strand
Health Lab
Researchers discover urine based test to detect head and neck cancer
At-home test can detect tumor DNA fragments in urine samples, providing a non-invasive alternative to traditional blood-based biomarker tests
Spilled pills next to a stethoscope and pile of cash
Health Lab
Drug pricing program improved prostate cancer treatment adherence
Socially vulnerable patients were more likely to stick with oral medications when treated at a hospital participating in 340B program, suggesting these hospitals may have more resources to help patients.